Meta-analysis indicated no significant difference in striatal DAT availability in MDD relative to controls with an effect size of −0.21 (95% CI, −0.71–0.30, p = 0.420, Figure 3(a)). This evidence concerns the gene SLC6A3 and major depressive disorder.